The world of marketing to patients and physicians is changing dramatically.
Interesting New Ortho Marketing Company Formed
1 min read Premium comments
Secondary
Two-thirds of all American adults, for example, engage with Facebook. Forty percent get news there. The process of communicating products, features and benefits is no longer about “awareness.” It is, instead, about engagement and community building. These new concepts are the new sales drivers.
This shift in media consuming habits has major ramifications for orthopedics companies.
To help orthopedic companies navigate this new world, a new marketing company has been formed by two orthopedic industry veterans—Michael Spiegler and Gennady Gomez.
Say “Hello” to MPM
Medical and Pharmaceutical Marketing (MPM), located in New York City, is a new generation of marketing service firms—not only fluent in the language of digital media but is also firmly grounded in the fundamentals of market research and business intelligence.
Combining years of sales and marketing experience, both in the U.S. and abroad, founders Michael Spiegler and Gennady Gomez are well-versed in working alongside orthopedic companies to hone, refine, and expand critical product messaging efforts.
On the digital media side, MPM covers:
- Web Development
- SEO
- Public Relations
- Video Marketing
- Email Marketing
- Data & Analytics
- Social Media
Their website is at www.mpmfirst.com.
Give them a test drive. It’s time you directed your marketing programs to where the patients and their physicians can engage with you.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.